PHENOTYPIC DETERMINATION OF INDUCIBLE CLINDAMYCIN RESISTANT AND METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS FROM CLINICAL ISOLATES OF KHYBER TEACHING HOSPITAL, PESHAWAR
-
Published:2023-07-05
Issue:1
Volume:2023
Page:41
-
ISSN:2521-0092
-
Container-title:Bulletin of Biological and Allied Sciences Research
-
language:
-
Short-container-title:Bull. Biol. All. Sci. Res.
Author:
HAMID M,BASHIR K,RIZWAN M,KHILGEE FEA,AAMIR M,KHAYAM K
Abstract
Methicillin Resistant Staphylococcus aureus (MRSA) is a major pathogen involved in nosocomial infections and to some extent, in community acquired infections. Among Macrolide Lincosamine Streptogramin B (MLSB) class of drugs, Clindamycin was vigorously preferred for treating staphylococcal infections in the past few decades but, some genetic factors i.e. erm and msrA genes contribute in developing Inducible Clindamycin Resistance (iCR). Sensitivity tests performed on a routine basis cannot detect inducible resistance and may result in the failure of Clindamycin to be used as an effective medication. This study aimed to detect the phenotype of MRSA and iCR S. aureus from the clinical samples of Khyber Teaching Hospital, Peshawar. A total of 204 samples were collected randomly from each gender, 130 (63.72%) samples were isolated as S. aureus, while 74 (36.27%) were other bacterial species. Double disk diffusion (D-test) was performed to detect iCR phenotype, and 80 (61.5%) isolates showed iCR, while 50 (38.4%) were negative in this regard. MRSA phenotype was determined by strains conferring resistance to Cefoxitin antibiotic, which resulted in 84 (64.6%) isolates of MRSA and 46 (35.3%) of Methicillin Sensitive Staphylococcus aureus (MSSA). Antibiogram analysis showed efficient antimicrobial activity by Tigecycline 129 (99.2%), Fusidic Acid 126 (96.9%), and Doxycycline 124 (95.3%), while the highest resistance pattern was recorded against Ciprofloxacin 31(23.8%) and Clindamycin 28(21.5%). Our study concludes that misuse of antibiotics should be avoided to inhibit the spread of MRSA, and implementation of D-test regularly in hospitals is crucial.
Publisher
Medeye Publishers
Reference17 articles.
1. Adhikari, R., Shrestha, S., Barakoti, A., and Amatya, R. (2017). Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal. BMC infectious diseases 17, 1-5. https://doi.org/10.1186/s12879-017-2584-5 2. Aktas, Z., Aridogan, A., Kayacan, C. B., and Aydin, D. (2007). Resistance to macrolide, lincosamide and streptogramin antibiotics in staphylococci isolated in Istanbul, Turkey. The Journal of Microbiology 45, 286-290. 3. Elkammoshi, A. M., Ghasemzadeh-Moghaddam, H., Nordin, S. A., Taib, N. M., Subbiah, S. K., Neela, V., and Hamat, R. A. (2016). A low prevalence of inducible macrolide, lincosamide, and streptogramin b resistance phenotype among methicillin-susceptible Staphylococcus aureus isolated from malaysian patients and healthy individuals. Jundishapur journal of microbiology 9. https://doi.org/10.5812/jjm.37148 4. Fiebelkorn, K., Crawford, S., McElmeel, M., and Jorgensen, J. (2003). Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. Journal of clinical microbiology 41, 4740-4744. https://doi.org/10.1128/JCM.41.10.4740-4744.2003. 5. Fokas, S., Fokas, S., Tsironi, M., Kalkani, M., and Dionysopouloy, M. (2005). Prevalence of inducible clindamycin resistance in macrolide‐resistant Staphylococcus spp. Clinical microbiology and infection 11, 337-340. https://doi.org/10.1111/j.1469-0691.2005.01101.x
|
|